Full spectrum vs isolate: Which formulation wins for cannabis brands in 2026
The cannabidiol (CBD) market isn’t just growing – it’s fracturing into distinct camps. Full spectrum vs isolate formulations now represent a strategic choice that defines your brand positioning, customer base, and profit margins. With the CBD supplement market projected to reach $25 billion by 2035 and federal rescheduling of cannabis to Schedule III eliminating tax penalties, brands face a critical decision point.